A clinical OxyContin trial is in progress for children between the ages of 6 and 17, according to a CNN report. The trial will include 154 children with moderate to severe pain who have demonstrated a tolerance to opioids.
The FDA may give drug manufacturer Purdue Pharma a six-month extension of its original OxyContin patent as an incentive for the completed pediatric study.
Pain Management Physician Joins Coastal Orthopedics
Report: Florida Closed Half of Pain Management Clinics in Two Years
The FDA may give drug manufacturer Purdue Pharma a six-month extension of its original OxyContin patent as an incentive for the completed pediatric study.
Related Articles on Pain Management:
Study: Hospitals Struggle With Pediatric PainPain Management Physician Joins Coastal Orthopedics
Report: Florida Closed Half of Pain Management Clinics in Two Years